GLP-1 drugs outperform SGLT-2 drugs for patients with Afib and type 2 diabetes. Individuals with atrial fibrillation (Afib), or irregular heart rhythm, are at increased risk of stroke, chronic kidney disease and heart failure.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: Individuals with atrial fibrillation (Afib), or irregular heart rhythm, are at increased risk of stroke, chronic kidney disease and heart failure. These risks are significantly exacerbated if a type 2 diabetes diagnosis is added to the mix, says Md Mohaimenul Islam, Ph.D., research assistant professor in the Department of Pharmacy Practice in the University at Buffalo School of Pharmacy and Pharmaceutical Sciences.
- Ponto de atenção: drugs.
- Ponto de atenção: outperform.
- Ponto de atenção: sglt.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
:quality(85)/714bb402-38e3-43bf-8898-7556dcd88307.jpeg)
:quality(85)/b2559bc4-a3f9-4524-8599-e1e7c27867ef.png)
